1. CoreAge Rx Spot On — sponsored first placement
CoreAge’s current Spot On sales page identifies hydroquinone 6%, kojic acid 6% and niacinamide on its plan cards. The niacinamide percentage and complete dispensed formulation remain unverified. The main product page supplies the broader ingredient description; neither source establishes that this exact compounded blend produces better outcomes than the other offers.
The plans show $165 for three months ($54.99 monthly display) or $70 for one ($69.99 display). A separate Spot On information block on that same sales page says from $42/month, which conflicts with the plans. Free shipping, no long-term contracts and physician non-approval refund are advertised; the PDP also advertises no membership fees. The CoreAge review records the discrepancy, rounding and unverified checkout details. Its first position reflects common ownership and sponsorship, with no clinical superiority finding.
Wisp Brighten Up! — disclosed strengths and one-time orders
Wisp publishes hydroquinone 5%, vitamin C 1% and niacinamide 4% for Brighten Up!, with a 1.69 fl oz bottle and a $90 display price. The medication details provide more formulation information than the headline alone. We do not interpret that ingredient combination as evidence of superior outcomes compared with the other offers.
Wisp’s treatment page states that hydroquinone requires a new one-time order for refills and is not on a subscription plan. We did not establish a fixed monthly equivalent for the displayed bottle. Our Wisp review also explains why the company-wide ratings beside the product are not a cream-specific efficacy score. Confirm bottle duration and clinical review arrangements with the prescribing team.
Nurx hydroquinone 4% — separate medicine and care periods
Nurx’s medicine display is $90 for a three-month supply. Its melasma consultation costs $40 and includes a year of care and messaging, while a $3 support fee applies in months when an order is processed. These are different billing units, and they should stay visible in a fair comparison. See the Nurx product page and the associated melasma pricing information.
The $30 monthly medicine equivalent is mathematically useful but does not represent the complete first payment. A first-order illustration combining the three stated charges is $133. The Nurx review explains the assumptions and why neither a three-month tube nor a year of messaging determines how long a patient should continue hydroquinone. Confirm the actual product label and shipping schedule before purchase.
RedBox Rx hydroquinone 4% — quarterly billing and further questions
RedBox describes a 28.35 g tube, $20 per month billed as $60 every three months, and a $25 consultation when using its pharmacy. Its general FAQ adds a $1.50 prescription-order handling charge and describes different consultation pricing for an outside pharmacy. Ask about any continuation charges rather than assuming the first invoice repeats unchanged.
The product page also calls the medicine FDA approved. We have not verified that claim for the actual dispensed product, and an NDC or an ingredient strength does not settle it. The RedBox Rx review documents that limitation without claiming that an unrelated label identifies its supply. Ask the provider for the actual manufacturer and approval record before treating the wording as verified.
Compare the same question across all four
There is no meaningful “cheapest” conclusion if one column shows a monthly starting amount, another shows an unconverted bottle, and another excludes consultation charges. Ask each provider for the total payable today, the dispensed quantity, the intended supply period and the next charge. The cost guide works through these distinctions using the public figures above.
Formula comparisons need the same discipline. CoreAge now markets 6% hydroquinone with 6% kojic and niacinamide of unstated strength, Wisp lists a different three-ingredient preparation, and the Nurx and RedBox listings describe 4% hydroquinone. Those facts cannot produce a clinical leaderboard. We have not purchased the products, audited the pharmacies or identified a direct comparative trial of these four exact offers. No numerical medical ratings are assigned.
Safety and follow-up belong in the shortlist
Hydroquinone requires more thought than choosing an ordinary moisturizer. FDA describes risks including abnormal darkening and skin reactions, while dermatology guidance places pigmentation treatment within diagnosis and sun protection. Discuss pregnancy, breastfeeding, allergies and other products during assessment. A clinician may recommend a different treatment or an in-person examination, and a review site cannot override that judgment.
Use the shortlist builder to select providers and download their public facts with source links and unresolved questions. It does not score your skin, collect symptoms or issue a treatment recommendation. The strongest purchasing record is one that preserves uncertainty long enough to get an answer: the exact preparation, the complete bill, a checked pharmacy and a clear date for clinical reassessment.
Beyond these four service offers, the Musely Spot Cream review examines several possible formulas and a conditional result guarantee. It is an additional document-based review, without a clinical rank or an assumption that the strongest advertised concentration is preferable.